XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Accounting Policies [Abstract] |
Schedule of Cash and Cash Equivalents | The following table provides a reconciliation of cash and cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):
| September 30, 2025 |  | December 31, 2024
Cash and cash equivalents | $ | 274,150 |  |  | $ | 161,435 |
Restricted cash | 6,148 |  |  | 6,137 |
Total cash, cash equivalents and restricted cash | $ | 280,298 |  |  | $ | 167,572 |
Schedule of Restrictions on Cash and Cash Equivalents | The following table provides a reconciliation of cash and cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):
| September 30, 2025 |  | December 31, 2024
Cash and cash equivalents | $ | 274,150 |  |  | $ | 161,435 |
Restricted cash | 6,148 |  |  | 6,137 |
Total cash, cash equivalents and restricted cash | $ | 280,298 |  |  | $ | 167,572 |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except shares and per share data):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Numerator: |  |  |  |  |  |  |
Net income (loss) from continuing operations | $ | (18,866) |  |  | $ | (54,684) |  |  | $ | 161,596 |  |  | $ | (136,846) |
Less: net (income) loss attributable to non-controlling interest | — |  |  | 425 |  |  | 1 |  |  | 1,454 |
Net income (loss) from continuing operations available to common shareholders | (18,866) |  |  | (54,259) |  |  | 161,597 |  |  | (135,392) |
Net income (loss) from discontinued operations, net of tax | — |  |  | 1,836 |  |  | — |  |  | 1,687 |
Net income (loss) attributable to common shareholders - basic | $ | (18,866) |  |  | $ | (52,423) |  |  | $ | 161,597 |  |  | $ | (133,705) |
Add: Dilutive effect of convertible notes, net (1) | — |  |  | — |  |  | 8,376 |  |  | — |
Net income (loss) attributable to common shareholders - diluted | $ | (18,866) |  |  | $ | (52,423) |  |  | $ | 169,973 |  |  | $ | (133,705) |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares outstanding - basic | 342,504,107 |  |  | 331,582,813 |  |  | 341,752,619 |  |  | 314,126,997 |
Convertible notes | — |  |  | — |  |  | 46,266,486 |  |  | — |
Common stock options and restricted stock units | — |  |  | — |  |  | 16,633,110 |  |  | — |
Weighted-average common shares outstanding - diluted | 342,504,107 |  |  | 331,582,813 |  |  | 404,652,215 |  |  | 314,126,997 |
Net income (loss) per share - basic |  |  |  |  |  |  |
Continuing operations | $ | (0.06) |  |  | $ | (0.17) |  |  | $ | 0.47 |  |  | $ | (0.44) |
Discontinued operations | $ | — |  |  | $ | 0.01 |  |  | $ | — |  |  | $ | 0.01 |
Total net income (loss) per share - basic | $ | (0.06) |  |  | $ | (0.16) |  |  | $ | 0.47 |  |  | $ | (0.43) |
Net income (loss) per share - diluted |  |  |  |  |  |  |
Continuing operations | $ | (0.06) |  |  | $ | (0.17) |  |  | $ | 0.42 |  |  | $ | (0.44) |
Discontinued operations | $ | — |  |  | $ | 0.01 |  |  | $ | — |  |  | $ | 0.01 |
Total net income (loss) per share - diluted | $ | (0.06) |  |  | $ | (0.16) |  |  | $ | 0.42 |  |  | $ | (0.43) |
(1) Reflects interest expense incurred, net of tax, associated with convertible note activity during the period as evaluated under the if-converted method.
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share | The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:
| Three Months Ended September 30, |  | Nine Months Ended September 30, |
| 2025 |  | 2024 |  | 2025 |  | 2024 |
Warrants to purchase common stock | — |  |  | 166,670 |  |  | — |  |  | 166,670 |  |
Stock options | 16,491,907 |  |  | 18,846,277 |  |  | 14,964,036 |  |  | 18,846,277 |  |
Unvested restricted stock units | 32,604,690 |  |  | 22,284,523 |  |  | 1,676,126 |  |  | 22,284,523 |  |
Convertible notes variable settlement feature | 48,771,938 |  |  | 48,771,938 |  |  | 2,505,452 |  |  | 48,771,938 |  |
Total | 97,868,535 |  |  | 90,069,408 |  |  | 19,145,614 |  |  | 90,069,408 |  |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 8 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration